PROSER1 modulates DNA demethylation through dual mechanisms to prevent syndromic developmental malformations
Genes & Development · 2024
DOI: 10.1101/gad.352176.124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Development, 2024. Verfasst von Anna Fleming und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular, Cellular, and Developmental Biology, University of Dundee, Dundee DD1 5EH, United Kingdom. Hauptthemen laut MEDLINE: DNA Demethylation, Gene Expression Regulation, Developmental. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, Cancer Research UK, China Scholarship Council.
Abstract (Originalsprache)
The link between DNA methylation and neurodevelopmental disorders is well established. However, how DNA methylation is fine-tuned—ensuring precise gene expression and developmental fidelity—remains poorly understood. PROSER1, a known TET2 interactor, was recently linked to a severe neurodevelopmental disorder. Here, we demonstrate that PROSER1 interacts with all TET enzymes and stabilizes chromatin-bound TET–OGT–PROSER1–DBHS (TOPD) complexes, which regulate DNA demethylation and developmental gene expression. Surprisingly, we found that PROSER1 also sequesters TET enzymes, preventing widespread demethylation and transposable element derepression. Our findings identify PROSER1 as a key factor that both positively and negatively regulates DNA demethylation essential for mammalian neurodevelopment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Molecular, Cellular, and Developmental Biology, University of Dundee, Dundee DD1 5EH, United Kingdom.
- Centre for Regenerative Medicine, Institute for Regeneration and Repair, Institute for Stem Cell Research, University of Edinburgh, Edinburgh EH16 4UU, United Kingdom.
- Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, United Kingdom.
- MRC Laboratory of Medical Sciences, London W12 0NN, United Kingdom.
- Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London SW7 2AZ, United Kingdom.
- Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
ORCID-Profile: Kasper D Rasmussen
Förderung
- NIH HHS
- Cancer Research UK
- China Scholarship Council
- MRC
- Funding 815
- ERC
- Hevolution Foundation
- Einstein-Mount Sinai Diabetes Center
Zitieren
APA
Fleming, A., Knatko, E. V., Li, X., Zoch, A., Heckhausen, Z., Stransky, S., Brenes, A. J., Sidoli, S., Hajkova, P., O'Carroll, D., & Rasmussen, K. D. (2024). PROSER1 modulates DNA demethylation through dual mechanisms to prevent syndromic developmental malformations. Genes & Development. https://doi.org/10.1101/gad.352176.124
Vancouver
Fleming A, Knatko EV, Li X, Zoch A, Heckhausen Z, Stransky S, et al. PROSER1 modulates DNA demethylation through dual mechanisms to prevent syndromic developmental malformations. Genes & Development. 2024. doi:10.1101/gad.352176.124
BibTeX
@article{Fleming2024,
author = {Fleming, Anna and Knatko, Elena V and Li, Xiang and Zoch, Ansgar and Heckhausen, Zoe and Stransky, Stephanie and Brenes, Alejandro J and Sidoli, Simone and Hajkova, Petra and O'Carroll, Dónal and Rasmussen, Kasper D},
title = {PROSER1 modulates DNA demethylation through dual mechanisms to prevent syndromic developmental malformations},
journal = {Genes & Development},
year = {2024},
doi = {10.1101/gad.352176.124}
}
EUVIMED